Who is sponsoring NCT03806361?

NCT03806361 is sponsored by Hospital Sirio-Libanes.

What drugs are being tested in NCT03806361?

Interventions in NCT03806361: Fat grafts supplemented with ADRC, Structural fat grafting.

What condition does NCT03806361 study?

NCT03806361 studies Craniofacial Microsomia.

Is NCT03806361 still recruiting?

NCT03806361 is currently completed. Last updated 18 October 2021.

Last reviewed 2021-10-18 · How we verify

NCT03806361

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fat Grafts With Adipose-derived Regenerative Cells for Soft Tissue Reconstruction in Children

Completed NA Last updated 18 October 2021

What this trial tests

NA trial testing Fat grafts supplemented with ADRC in Craniofacial Microsomia in 30 participants. Completed in 10 January 2021.

Timeline

10 January 2019

Primary endpoint
10 January 2021

10 January 2021

Quick facts

Lead sponsor	Hospital Sirio-Libanes
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	10 January 2019
Primary completion	10 January 2021
Estimated completion	10 January 2021
Sites	1 location across Brazil

Drugs / interventions tested

Fat grafts supplemented with ADRC
Structural fat grafting

Conditions studied

Craniofacial Microsomia — all drugs for Craniofacial Microsomia →

Sponsor

Hospital Sirio-Libanes

Who can join

Adults 10 to 18, any sex, with Craniofacial Microsomia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although first reports of the clinical use of adipose-derived regenerative cells (ADRC) suggest that this approach may be feasible and effective for soft tissue augmentation, there is a lack of randomized, controlled clinical trials in the literature. Hence, this study aimed to investigate whether a novel protocol for isolation of ADRC and their use in combination with fat tissue improve the long-term retention of the grafts in paediatric patients with craniofacial microsomia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Hospital Sirio-Libanes trials

Trials by the same sponsor.

NCT07089134 — Virtual Reality in Intensive Care Unit: Patient Satisfaction, Clinical and Functional Outcomes, Feasibility · NA · not yet recruiting
NCT06479031 — Occupational Therapy Intervention on the Prevention of Delirium and Occupational Performance Status in Elderly Patients · NA · not yet recruiting
NCT06339632 — Effects of Transcutaneous Electrical Phrenic Nerve Stimulation and Transcutaneous Electrical Diaphragmatic Stimulation · NA · recruiting
NCT05950269 — Walking Aid and Locomotion Knowledge in Emergency Rooms (WALKER 1) for Elderly People · NA · completed
NCT05840458 — Pericapsular Nerve Block in Proximal Femoral Fractures · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03806361 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Sirio-Libanes
Last refreshed: 18 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03806361.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing